Regenxbio Cash Flow Statement (2014-2025) | RGNX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-50.14M	-57.64M	-58.41M	294.02M	-76.72M	-68.18M	-75.48M	279.21M	-66.68M	-72.06M	-61.87M	-62.97M	-73.95M	-54.09M	-60.10M	-66.62M	3.54M	-70.89M	-65.48M	89.82M
Share-based Compensation (Quarter)	9.92M	9.99M	9.73M	9.16M	10.80M	10.34M	10.24M	9.41M	11.21M	10.50M	10.22M	8.34M	9.60M	9.44M	9.88M	9.54M	8.54M	65.60M	9.00M	8.38M
Asset Writedowns and Impairment (Quarter)													0.70M
Cash from Operations (Quarter)	-44.05M	-36.07M	-42.50M	341.50M	-55.91M	-61.75M	-50.46M	-39.37M	-80.92M	-47.32M	-49.41M	-40.76M	-55.45M	-45.50M	-40.55M	-31.62M	33.63M	-49.34M	-55.96M	-52.29M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-1.29M	-1.58M	-1.51M	-1.47M	-1.46M	-1.22M	-1.13M	-0.90M	-0.68M	-0.38M	0.13M	0.24M	0.47M	1.24M	1.32M	1.12M	1.07M	1.36M	1.82M	1.23M
Amortization of Deferred Charges (Quarter)	3.79M	0.17M	0.56M	0.12M	0.05M	0.82M	-0.11M	-0.63M	-0.57M	-0.66M	0.67M	0.15M	0.69M	-0.71M	0.44M	5.69M	-0.28M	2.77M	5.30M	5.11M
Depreciation & Amortization (CF) (Quarter)	1.93M	2.20M	2.83M	2.61M	2.59M	2.64M	3.55M	4.13M	4.18M	4.43M	4.37M	4.32M	4.18M	4.05M	3.96M	4.01M	3.96M	3.90M	3.89M	3.87M
Change in Working Capital
Change in Receivables (Quarter)	-1.62M	3.10M	6.40M	-22.00M	-5.69M	10.72M	-5.01M	-4.84M	-9.49M	2.39M	6.54M	-3.37M	-9.18M	6.89M	0.71M	-8.13M	-1.57M	2.36M	6.31M	0.56M
Change in Account Payables (Quarter)	0.28M	-1.12M	7.35M	-8.81M	16.75M	-7.23M	7.36M	1.91M	-3.10M	-11.01M	10.10M	1.22M	8.46M	-14.91M	3.12M	3.04M	-3.65M	2.53M	0.69M	-1.86M
Change in Accured Expenses (Quarter)	-10.54M	10.57M	-0.03M	0.29M	6.93M	-32.53M	33.53M	-33.56M	-15.44M	12.70M	0.11M	0.12M	-2.76M	-4.79M	6.10M	-1.16M	-14.49M	11.52M	3.15M	0.04M
Other Working Capital Changes (Quarter)	4.24M	-1.14M	0.20M	4.01M	-3.04M	6.51M	-3.52M	-0.20M	13.65M	-17.00M	-1.66M	15.55M	-0.14M	-3.89M	4.02M	-0.03M	39.77M	-44.17M	9.98M	-14.21M
Investing Activities
Capital Expenditures (Quarter)	3.79M	-1.38M	67.15M	-67.29M	10.97M	-11.49M	2.44M	-1.95M	4.82M	-7.38M	11.40M	-10.42M	0.56M	-2.42M	1.39M	-0.33M	1.02M	-3.15M	2.39M	2.15M
Change in Acquisitions & Divestments (Quarter)	50.47M	36.01M	49.92M	33.70M	49.86M	37.03M	72.12M	44.13M	67.91M	107.59M	-173.53M	283.52M	68.93M	82.73M	86.78M	-232.66M	64.92M	71.10M	82.24M	-218.19M
Cash from Investing Activities (Quarter)	-214.18M	7.80M	16.10M	-216.36M	-90.59M	-1.08M	53.04M	26.70M	63.09M	55.22M	38.66M	33.97M	13.18M	-0.27M	50.26M	40.27M	44.74M	-140.44M	42.29M	37.54M
Financing Activities
Other financing activities (Quarter)	1.29M	0.28M	0.20M	2.53M	0.62M		2.14M	0.04M		0.58M	0.73M	0.51M	0.41M	0.67M	0.40M	0.04M	0.15M	0.08M		0.09M
Cash from Financing Activities (Quarter)	211.29M	-6.14M	-2.28M	-7.62M	-6.83M	-7.67M	-5.42M	-8.92M	-9.04M	-9.16M	-4.80M	-11.96M	120.72M	-9.45M	-10.86M	-7.74M	-5.79M	139.23M	-7.08M	-9.58M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)	-46.94M	-34.41M	-28.68M	117.52M	-153.34M	-70.50M	-2.83M	-21.59M	-26.86M	-1.27M	-15.55M	-18.75M	78.45M	-55.21M	-1.15M	0.91M	72.58M	-50.55M	-20.76M	-24.34M
Free Cash Flow (Quarter)	-47.84M	-34.70M	-109.65M	408.79M	-66.88M	-50.26M	-52.90M	-37.42M	-85.74M	-39.94M	-60.80M	-30.34M	-56.01M	-43.08M	-41.94M	-31.29M	32.60M	-46.20M	-58.35M	-54.44M
Net Cash Flow (Quarter)	-46.94M	-34.41M	-28.68M	117.52M	-153.34M	-70.50M	-2.83M	-21.59M	-26.86M	-1.27M	-15.55M	-18.75M	78.45M	-55.21M	-1.15M	0.91M	72.58M	-50.55M	-20.76M	-24.34M

Research Tools

Developers

Regenxbio Cash Flow Statement (2014-2025) | RGNX

Research Tools

Developers

Regenxbio Cash Flow Statement (2014-2025) | RGNX

Create an account

Sign In

Reset Password